Product
B013
1 clinical trial
1 indication
Indication
Ovarian CancerClinical trial
A Multicenter, Randomized, Double-blind, Parallel-controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of B013 Combined With Paclitaxel in the Treatment of Platinum-resistant Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer.Status: Not yet recruiting, Estimated PCD: 2026-12-31